10x Genomics Revenue 2018-2026 | TXG
10x Genomics annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- 10x Genomics revenue for the quarter ending June 30, 2026 was $0.151B, a 12.65% decline year-over-year.
- 10x Genomics revenue for the twelve months ending June 30, 2026 was $0.617B, a 4.28% decline year-over-year.
- 10x Genomics annual revenue for 2025 was $0.643B, a 5.25% increase from 2024.
- 10x Genomics annual revenue for 2024 was $0.611B, a 1.28% decline from 2023.
- 10x Genomics annual revenue for 2023 was $0.619B, a 19.81% increase from 2022.
|
10x Genomics Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $643 |
| 2024 | $611 |
| 2023 | $619 |
| 2022 | $516 |
| 2021 | $490 |
| 2020 | $299 |
| 2019 | $246 |
| 2018 | $146 |
| 2017 | $71 |
|
10x Genomics Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2026-06-30 | $151 |
| 2026-03-31 | $151 |
| 2025-12-31 | $166 |
| 2025-09-30 | $149 |
| 2025-06-30 | $173 |
| 2025-03-31 | $155 |
| 2024-12-31 | $165 |
| 2024-09-30 | $152 |
| 2024-06-30 | $153 |
| 2024-03-31 | $141 |
| 2023-12-31 | $184 |
| 2023-09-30 | $154 |
| 2023-06-30 | $147 |
| 2023-03-31 | $134 |
| 2022-12-31 | $156 |
| 2022-09-30 | $131 |
| 2022-06-30 | $115 |
| 2022-03-31 | $114 |
| 2021-12-31 | $144 |
| 2021-09-30 | $125 |
| 2021-06-30 | $116 |
| 2021-03-31 | $106 |
| 2020-12-31 | $112 |
| 2020-09-30 | $72 |
| 2020-06-30 | $43 |
| 2020-03-31 | $72 |
| 2019-12-31 | $75 |
| 2019-09-30 | $61 |
| 2019-06-30 | $56 |
| 2019-03-31 | $54 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $9.135B | $0.643B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |